Phathom Pharmaceuticals, Inc. (PHAT)
NASDAQ·Healthcare·Biotechnology
$8.38
-6.68%
Mkt Cap $697.86M
Analyst Ratings
Buy
6
Hold
0
Sell
0
Price Target (19 analysts)
$22.00
Range $18.00 – $28.00
Implied Upside
+162.5%
Consensus $22.00 vs current $8.38
NASDAQ·Healthcare·Biotechnology
$8.38
-6.68%
Mkt Cap $697.86M
Buy
6
Hold
0
Sell
0
Price Target (19 analysts)
$22.00
Range $18.00 – $28.00
+162.5%
Consensus $22.00 vs current $8.38